Improving Treatment for Advanced Prostate Cancer

被引：12

作者：

Tannock, Ian F. ^{[1
,2
]}

机构：

[1] Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada

[2] Univ Toronto, Toronto, ON, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 381卷 / 02期

关键词：

ABIRATERONE;

D O I：

10.1056/NEJMe1906363

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：176 / 177

页数：2

共 10 条

[1] Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven [J].

Attard, Gerhardt ;

Reid, Alison H. M. ;

Yap, Timothy A. ;

Raynaud, Florence ;

Dowsett, Mitch ;

Settatree, Sarah ;

Barrett, Mary ;

Parker, Christopher ;

Martins, Vanessa ;

Folkerd, Elizabeth ;

Clark, Jeremy ;

Cooper, Colin S. ;

Kaye, Stan B. ;

Dearnaley, David ;

Lee, Gloria ;

de Bono, Johann S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4563-4571

[2] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer [J].

Chi, Kim N. ;

Agarwal, Neeraj ;

Bjartell, Anders ;

Chung, Byung Ha ;

Pereira de Santana Gomes, Andrea J. ;

Given, Robert ;

Juarez Soto, Alvaro ;

Merseburger, Axel S. ;

Ozguroglu, Mustafa ;

Uemura, Hirotsugu ;

Ye, Dingwei ;

Deprince, Kris ;

Naini, Vahid ;

Li, Jinhui ;

Cheng, Shinta ;

Yu, Margaret K. ;

Zhang, Ke ;

Larsen, Julie S. ;

McCarthy, Sharon ;

Chowdhury, Simon .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) :13-24

[3]

Claxton G, 2019, DOES COST AFFECT ACC

[4] Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer [J].

Davis, Ian D. ;

Martin, Andrew J. ;

Stockler, Martin R. ;

Begbie, Stephen ;

Chi, Kim N. ;

Chowdhury, Simon ;

Coskinas, Xanthi ;

Frydenberg, Mark ;

Hague, Wendy E. ;

Horvath, Lisa G. ;

Joshua, Anthony M. ;

Lawrence, Nicola J. ;

Marx, Gavin ;

McCaffrey, John ;

McDermott, Ray ;

McJannett, Margaret ;

North, Scott A. ;

Parnis, Francis ;

Parulekar, Wendy ;

Pook, David W. ;

Reaume, M. Neil ;

Sandhu, Shahneen K. ;

Tan, Alvin ;

Tan, T. Hsiang ;

Thomson, Alastair ;

Tu, Emily ;

Vera-Badillo, Francisco ;

Williams, Scott G. ;

Yip, Sonia ;

Zhang, Alison Y. ;

Zielinski, Robert R. ;

Sweeney, Christopher J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) :121-131

[5] Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial [J].

Fizazi, Karim ;

NamPhuong Tran ;

Fein, Luis ;

Matsubara, Nobuaki ;

Rodriguez-Antolin, Alfredo ;

Alekseev, Boris Y. ;

Ozguroglu, Mustafa ;

Ye, Dingwei ;

Feyerabend, Susan ;

Protheroe, Andrew ;

Sulur, Giri ;

Luna, Yesenia ;

Li, Susan ;

Mundle, Suneel ;

Chi, Kim N. .

LANCET ONCOLOGY, 2019, 20 (05) :686-700

[6] Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy [J].

James, N. D. ;

de Bono, J. S. ;

Spears, M. R. ;

Clarke, N. W. ;

Mason, M. D. ;

Dearnaley, D. P. ;

Ritchie, A. W. S. ;

Amos, C. L. ;

Gilson, C. ;

Jones, R. J. ;

Matheson, D. ;

Miliman, R. ;

Attard, G. ;

Chowdhury, S. ;

Cross, W. R. ;

Gillessen, S. ;

Parker, C. C. ;

Russell, J. M. ;

Berthold, D. R. ;

Brawley, C. ;

Adab, F. ;

Aung, S. ;

Birtle, A. J. ;

Bowen, J. ;

Brock, S. ;

Chakraborti, P. ;

Ferguson, C. ;

Gale, J. ;

Gray, E. ;

Hingorani, M. ;

Hoskin, P. J. ;

Lester, J. F. ;

Malik, Z. I. ;

McKinna, F. ;

McPhail, N. ;

Money-Kyrle, J. ;

O'Sullivan, J. ;

Parikh, O. ;

Protheroe, A. ;

Robinson, A. ;

Srihari, N. N. ;

Thomas, C. ;

Wagstaff, J. ;

Wylie, J. ;

Zarkar, A. ;

Parmar, M. K. B. ;

Sydes, M. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :338-351

[7]

Knight TG., 2018, J Oncol Pract

[8] Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer [J].

Locke, Jennifer A. ;

Guns, Emma S. ;

Lubik, Amy A. ;

Adomat, Hans H. ;

Hendy, Stephen C. ;

Wood, Catherine A. ;

Ettinger, Susan L. ;

Gleave, Martin E. ;

Nelson, Colleen C. .

CANCER RESEARCH, 2008, 68 (15) :6407-6415

[9] Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer [J].

Szmulewitz, Russell Z. ;

Peer, Cody J. ;

Ibraheem, Abiola ;

Martinez, Elia ;

Kozloff, Mark F. ;

Carthon, Bradley ;

Harvey, R. Donald ;

Fishkin, Paul ;

Yong, Wei Peng ;

Chiong, Edmund ;

Nabhan, Chadi ;

Karrison, Theodore ;

Figg, William D. ;

Stadler, Walter M. ;

Ratain, Mark J. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1389-+

[10] Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer [J].

Tran, Chris ;

Ouk, Samedy ;

Clegg, Nicola J. ;

Chen, Yu ;

Watson, Philip A. ;

Arora, Vivek ;

Wongvipat, John ;

Smith-Jones, Peter M. ;

Yoo, Dongwon ;

Kwon, Andrew ;

Wasielewska, Teresa ;

Welsbie, Derek ;

Chen, Charlie Degui ;

Higano, Celestia S. ;

Beer, Tomasz M. ;

Hung, David T. ;

Scher, Howard I. ;

Jung, Michael E. ;

Sawyers, Charles L. .

SCIENCE, 2009, 324 (5928) :787-790

← 1 →